BioMarin Pharmaceutical | Satış Ve Yönetim Giderleri

Selling And Administration Expenses Değişiklik Tarih
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Bayer EUR 3.6B 81M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
Incyte USD 293.86M 25.97M 2023-12
Insmed USD 89.53M 1.1M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Moderna USD 470M 28M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
United Therapeutics USD 128.6M 1000K 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



BioMarin Pharmaceutical Satış Ve Yönetim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Apr 2024.